$CVS
CVS HEALTH Corp Stock $cvs

$cvs Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000006480315000054 Filed on August 04, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$37.17B	$34.60B
YoY Change	7.42%	10.73%
Cost Of Revenue	$30.77B	$28.28B
YoY Change	8.8%	11.3%
Gross Profit	$6.402B	$6.324B
YoY Change	1.23%	8.27%
Gross Profit Margin	17.22%	18.28%
Selling, General & Admin	$4.140B	$4.116B
YoY Change	0.58%	6.38%
% of Gross Profit	64.67%	65.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$4.140B	$4.116B
YoY Change	0.58%	6.38%
Operating Profit	$2.262B	$2.208B
YoY Change	2.45%	11.97%
Interest Expense	$171.0M	$161.0M
YoY Change	6.21%	26.77%
% of Operating Profit	7.56%	7.29%
Other Income/Expense, Net
YoY Change
Pretax Income	$2.096B	$2.050B
YoY Change	2.24%	11.05%
Income Tax	$824.0M	$804.0M
% Of Pretax Income	39.31%	39.22%
Net Earnings	$1.272B	$1.246B
YoY Change	2.09%	10.85%
Net Earnings / Revenue	3.42%	3.6%
Basic Earnings Per Share	$1.13	$1.07
Diluted Earnings Per Share	$1.12	$1.06
COMMON SHARES
Basic Shares Outstanding	1.124B shares	1.165B shares
Diluted Shares Outstanding	1.132B shares	1.174B shares

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.404B	$1.712B
YoY Change	-17.99%	45.21%
Cash & Equivalents	$1.244B	$1.612B
Short-Term Investments	$160.0M	$100.0M
Other Short-Term Assets	$732.0M	$554.0M
YoY Change	32.13%	34.14%
Inventory	$12.38B	$11.36B
Prepaid Expenses
Receivables	$10.89B	$9.533B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$26.40B	$24.14B
YoY Change	9.38%	21.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.019B	$8.820B
YoY Change	2.26%	1.29%
Goodwill	$28.12B	$28.13B
YoY Change	-0.01%	5.92%
Intangibles	$9.683B	$9.906B
YoY Change	-2.25%	2.58%
Long-Term Investments
YoY Change
Other Assets	$1.443B	$1.603B
YoY Change	-9.98%	7.15%
Total Long-Term Assets	$48.27B	$48.46B
YoY Change	-0.39%	4.4%
TOTAL ASSETS
Total Short-Term Assets	$26.40B	$24.14B
Total Long-Term Assets	$48.27B	$48.46B
Total Assets	$74.67B	$72.59B
YoY Change	2.86%	9.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.370B	$5.780B
YoY Change	10.21%	11.63%
Accrued Expenses	$5.543B	$4.812B
YoY Change	15.19%	37.45%
Deferred Revenue
YoY Change
Short-Term Debt	$1.488B	$0.00
YoY Change
Long-Term Debt Due	$24.00M	$1.119B
YoY Change	-97.86%	6116.67%
Total Short-Term Liabilities	$20.39B	$16.63B
YoY Change	22.59%	31.04%
LONG-TERM LIABILITIES
Long-Term Debt	$11.63B	$12.25B
YoY Change	-5.05%	30.93%
Other Long-Term Liabilities	$1.490B	$1.489B
YoY Change	0.07%	-2.93%
Total Long-Term Liabilities	$1.490B	$1.489B
YoY Change	0.07%	-86.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.39B	$16.63B
Total Long-Term Liabilities	$1.490B	$1.489B
Total Liabilities	$21.88B	$18.12B
YoY Change	20.74%	-23.17%
SHAREHOLDERS EQUITY
Retained Earnings	$33.54B	$30.22B
YoY Change	11.0%	13.73%
Common Stock	$17.00M	$17.00M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$26.99B	$22.13B
YoY Change	21.95%	30.28%
Treasury Stock Shares	578.0M shares	527.0M shares
Shareholders Equity	$37.13B	$38.13B
YoY Change
Total Liabilities & Shareholders Equity	$74.67B	$72.59B
YoY Change	2.86%	9.52%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	$1.272B	$1.246B
YoY Change	2.09%	10.85%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$1.037B	$897.0M
YoY Change	15.61%	-0.55%
INVESTING ACTIVITIES
Capital Expenditures	-$523.0M	-$503.0M
YoY Change	3.98%	3.5%
Acquisitions
YoY Change
Other Investing Activities	-$23.00M	-$122.0M
YoY Change	-81.15%	205.0%
Cash From Investing Activities	-$546.0M	-$625.0M
YoY Change	-12.64%	18.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-761.0M	-1.423B
YoY Change	-46.52%	89.48%
NET CHANGE
Cash From Operating Activities	1.037B	897.0M
Cash From Investing Activities	-546.0M	-625.0M
Cash From Financing Activities	-761.0M	-1.423B
Net Change In Cash	-270.0M	-1.151B
YoY Change	-76.54%	206.93%
FREE CASH FLOW
Cash From Operating Activities	$1.037B	$897.0M
Capital Expenditures	-$523.0M	-$503.0M
Free Cash Flow	$1.560B	$1.400B
YoY Change	11.43%	0.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	cvs	Intersegment Transactions Number Of Type Of Transactions IntersegmentTransactionsNumberOfTypeOfTransactions	2	type_of_transaction
CY2014Q4	cvs	Longtermdebtcurrentmaturitiesincludingcapitalleases Longtermdebtcurrentmaturitiesincludingcapitalleases	575000000	USD
CY2014Q4	cvs	Claims And Discounts Payable ClaimsAndDiscountsPayable	5404000000	USD
CY2015Q2	cvs	Claims And Discounts Payable ClaimsAndDiscountsPayable	6961000000	USD
	cvs	Deferred Income Tax Expense Benefit And Other Non Cash Items DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems	44000000	USD
	cvs	Deferred Income Tax Expense Benefit And Other Non Cash Items DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems	6000000	USD
CY2015Q2	cvs	Fine Paidbythe Companyforthe Settlementwiththe U.S.Attorneys Officeforthe Middle Districtof Florida FinePaidbytheCompanyfortheSettlementwiththeU.S.AttorneysOfficefortheMiddleDistrictofFlorida	22000000	USD
CY2015Q2	cvs	Guaranteed Store Leases GuaranteedStoreLeases	72	store_lease
CY2014Q2	cvs	Incomefromcontinuingoperationsattributabletocommonstockholders Incomefromcontinuingoperationsattributabletocommonstockholders	1246000000	USD
	cvs	Incomefromcontinuingoperationsattributabletocommonstockholders Incomefromcontinuingoperationsattributabletocommonstockholders	2375000000	USD
CY2015Q2	cvs	Incomefromcontinuingoperationsattributabletocommonstockholders Incomefromcontinuingoperationsattributabletocommonstockholders	1265000000	USD
	cvs	Incomefromcontinuingoperationsattributabletocommonstockholders Incomefromcontinuingoperationsattributabletocommonstockholders	2481000000	USD
CY2015Q2	cvs	Longtermdebtcurrentmaturitiesincludingcapitalleases Longtermdebtcurrentmaturitiesincludingcapitalleases	24000000	USD
CY2014Q4	cvs	Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases	11630000000	USD
CY2015Q2	cvs	Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases	11633000000	USD
CY2003Q4	cvs	Number Of Competitors Against Whom Putative Actions Are Filed NumberOfCompetitorsAgainstWhomPutativeActionsAreFiled	2	competitor
CY2003Q4	cvs	Number Of Pharmacies Filing Putative Action NumberOfPharmaciesFilingPutativeAction	2	pharmacy
	cvs	Numberof Distribution Centers Leased NumberofDistributionCentersLeased	10	distribution_center
CY2014Q2	cvs	Other Comprehensive Income Loss Before Reclassification Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax	6000000	USD
	cvs	Other Comprehensive Income Loss Before Reclassification Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax	15000000	USD
CY2015Q2	cvs	Other Comprehensive Income Loss Before Reclassification Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax	9000000	USD
	cvs	Other Comprehensive Income Loss Before Reclassification Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax	-39000000	USD
CY2015Q2	cvs	Participating Securities Distributedand Undistributed Earnings Loss ParticipatingSecuritiesDistributedandUndistributedEarningsLoss	7000000	USD
	cvs	Participating Securities Distributedand Undistributed Earnings Loss ParticipatingSecuritiesDistributedandUndistributedEarningsLoss	12000000	USD
CY2015Q1	cvs	Percentageofconsolidatedinventoriesimpactedbychangeinaccountingprinciple Percentageofconsolidatedinventoriesimpactedbychangeinaccountingprinciple	0.36
	cvs	Proceedsfrom Saleof Property Plantand Equipmentand Other Assets ProceedsfromSaleofPropertyPlantandEquipmentandOtherAssets	7000000	USD
	cvs	Proceedsfrom Saleof Property Plantand Equipmentand Other Assets ProceedsfromSaleofPropertyPlantandEquipmentandOtherAssets	14000000	USD
CY2014Q2	cvs	Segment Reporting Information Revenues Recorded By More Than One Reporting Segment SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment	1200000000	USD
	cvs	Segment Reporting Information Revenues Recorded By More Than One Reporting Segment SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment	2300000000	USD
CY2015Q2	cvs	Segment Reporting Information Revenues Recorded By More Than One Reporting Segment SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment	1200000000	USD
	cvs	Segment Reporting Information Revenues Recorded By More Than One Reporting Segment SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment	2400000000	USD
	cvs	Yearthe Last Lease Expires YeartheLastLeaseExpires	2026
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	dei	Document Type DocumentType	10-Q
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0000064803
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1114486195	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CVS HEALTH CORPORATION
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6547000000	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	6370000000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9687000000	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10892000000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5816000000	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5543000000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-149000000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-139000000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-132000000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-217000000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-264000000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-255000000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	30418000000	USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	30840000000	USD
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	77000000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	44000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	88000000	USD
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2200000	shares
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3600000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1800000	shares
CY2014Q4	us-gaap	Assets Assets	74187000000	USD
CY2015Q2	us-gaap	Assets Assets	74668000000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	25983000000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	26401000000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4089000000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1612000000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2481000000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1244000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2477000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1237000000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2014Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.275
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.550
CY2015Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.350
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.700
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3200000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3200000000	shares
CY2014Q4	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	31000000	USD
CY2015Q2	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	31000000	USD
CY2014Q4	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	1000000	shares
CY2015Q2	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	1000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1691000000	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1697000000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1140000000	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1118000000	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	17000000	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	17000000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1253000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2392000000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1281000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2455000000	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	28278000000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	55025000000	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	30767000000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	60935000000	USD
CY2015Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11700000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	985000000	USD
CY2015Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	989000000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	4036000000	USD
CY2015Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	4026000000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	965000000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	978000000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.03
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.20
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.01
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.19
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-3000000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1000000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	65000000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	97000000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	28142000000	USD
CY2015Q2	us-gaap	Goodwill Goodwill	28122000000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	6324000000	USD
	us-gaap	Gross Profit GrossProfit	12266000000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	6402000000	USD
	us-gaap	Gross Profit GrossProfit	12566000000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2050000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3916000000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2096000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4094000000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.07
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.03
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.13
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.20
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.06
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.01
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.12
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.19
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	804000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1541000000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	824000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1601000000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1483000000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1627000000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	521000000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1383000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	584000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1211000000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	33000000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-241000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	235000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	465000000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	74000000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-131000000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	23000000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	48000000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-30000000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-93000000	USD
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	9000000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	10000000	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8000000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8000000	shares
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9774000000	USD
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9683000000	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	161000000	USD
	us-gaap	Interest Expense InterestExpense	322000000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	171000000	USD
	us-gaap	Interest Expense InterestExpense	309000000	USD
CY2014Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-158000000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-316000000	USD
CY2015Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-166000000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-300000000	USD
	us-gaap	Interest Paid InterestPaid	331000000	USD
	us-gaap	Interest Paid InterestPaid	311000000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	11930000000	USD
CY2015Q2	us-gaap	Inventory Net InventoryNet	12384000000	USD
CY2014Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6000000	USD
CY2015Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	5000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000000	USD
CY2014Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	573000000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1139000000	USD
CY2015Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	579000000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1161000000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	74187000000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	74668000000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19027000000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	20386000000	USD
CY2015Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	12300000000	USD
CY2015Q2	us-gaap	Long Term Investments LongTermInvestments	160000000	USD
CY2003Q4	us-gaap	Loss Contingency Number Of Defendants LossContingencyNumberOfDefendants	2	entity
CY2014Q4	us-gaap	Minority Interest MinorityInterest	5000000	USD
CY2015Q2	us-gaap	Minority Interest MinorityInterest	6000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2358000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3167000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3185000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1090000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3069000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3021000000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	4116000000	USD
	us-gaap	Operating Expenses OperatingExpenses	8034000000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	4140000000	USD
	us-gaap	Operating Expenses OperatingExpenses	8172000000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2208000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	4232000000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2262000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	4394000000	USD
CY2014Q2	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	8000000	USD
	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	17000000	USD
CY2015Q2	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	8000000	USD
	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	16000000	USD
CY2014Q2	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	565000000	USD
	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	1122000000	USD
CY2015Q2	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	571000000	USD
	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	1145000000	USD
CY2014Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	568000000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1129000000	USD
CY2015Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	574000000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1150000000	USD
CY2014Q2	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	5000000	USD
	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	10000000	USD
CY2015Q2	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	5000000	USD
	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	11000000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	866000000	USD
CY2015Q2	us-gaap	Other Assets Current OtherAssetsCurrent	732000000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1445000000	USD
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1443000000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	15000000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-39000000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	17000000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	9000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-38000000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	1000000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	2000000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	1000000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1531000000	USD
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1490000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2001000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2934000000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	647000000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	794000000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	161000000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	124000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2248000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	112000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	891000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	942000000	USD
	us-gaap	Payments To Suppliers PaymentsToSuppliers	50268000000	USD
	us-gaap	Payments To Suppliers PaymentsToSuppliers	58129000000	USD
	us-gaap	Payments To Suppliers And Employees PaymentsToSuppliersAndEmployees	7787000000	USD
	us-gaap	Payments To Suppliers And Employees PaymentsToSuppliersAndEmployees	7935000000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000.0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000.0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Customers ProceedsFromCustomers	62932000000	USD
	us-gaap	Proceeds From Customers ProceedsFromCustomers	71014000000	USD
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	6000000	USD
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	9000000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	0	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	803000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	103000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	40000000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	266000000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	211000000	USD
CY2014Q2	us-gaap	Profit Loss ProfitLoss	1246000000	USD
	us-gaap	Profit Loss ProfitLoss	2375000000	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	1272000000	USD
	us-gaap	Profit Loss ProfitLoss	2493000000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8843000000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9019000000	USD
CY2014Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-1000000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-2000000	USD
CY2015Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	0	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-1000000	USD
CY2014Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	11000000	USD
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	27000000	USD
CY2015Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	3000000	USD
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	7000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	41000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	550000000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	31849000000	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	33544000000	USD
CY2014Q2	us-gaap	Revenues Revenues	34602000000	USD
	us-gaap	Revenues Revenues	67291000000	USD
CY2015Q2	us-gaap	Revenues Revenues	37169000000	USD
	us-gaap	Revenues Revenues	73501000000	USD
	us-gaap	Sale Leaseback Transaction Net Proceeds Investing Activities SaleLeasebackTransactionNetProceedsInvestingActivities	5000000	USD
	us-gaap	Sale Leaseback Transaction Net Proceeds Investing Activities SaleLeasebackTransactionNetProceedsInvestingActivities	34000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	77000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	88000000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4000000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.88
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	26000000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	56.31
CY2015Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	102.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y2M29D
CY2014Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	685000000	USD
CY2015Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1488000000	USD
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	34000000	USD
CY2015Q2	us-gaap	Short Term Investments ShortTermInvestments	160000000	USD
CY2015Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	9800000000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	37958000000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	37127000000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37963000000	USD
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37133000000	USD
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	550000000	shares
CY2015Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	578000000	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	24078000000	USD
CY2015Q2	us-gaap	Treasury Stock Value TreasuryStockValue	26988000000	USD
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1174000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1182000000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1132000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1134000000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1165000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1172000000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1124000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1126000000	shares

Files In Submission

Name	View Source	Status
0000064803-15-000054-index-headers.html	Edgar Link	pending
0000064803-15-000054-index.html	Edgar Link	pending
0000064803-15-000054.txt	Edgar Link	pending
0000064803-15-000054-xbrl.zip	Edgar Link	pending
cvs-20150331.xml	Edgar Link	completed
cvs-20150331.xsd	Edgar Link	pending
cvs-20150331_cal.xml	Edgar Link	unprocessable
cvs-20150331_def.xml	Edgar Link	unprocessable
cvs-20150331_lab.xml	Edgar Link	unprocessable
cvs-20150331_pre.xml	Edgar Link	unprocessable
cvs20150630-10q.htm	Edgar Link	pending
cvs20150630ex311.htm	Edgar Link	pending
cvs20150630ex312.htm	Edgar Link	pending
cvs20150630ex321.htm	Edgar Link	pending
cvs20150630ex322.htm	Edgar Link	pending
exhibit101barclayscommitme.htm	Edgar Link	pending
exhibit102creditagreementj.htm	Edgar Link	pending
exhibit102creditagree_image1.gif	Edgar Link	pending
exhibit151q215eyconsent.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVS
CVS HEALTH Corp Stock $cvs

2015 Q2 Form 10-Q Financial Statement

#000006480315000054 Filed on August 04, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVS CVS HEALTH Corp Stock $cvs

2015 Q2 Form 10-Q Financial Statement

#000006480315000054 Filed on August 04, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVS
CVS HEALTH Corp Stock $cvs